Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174
-
Shares outstanding
-
55,833,616
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
16,966,777
-
Shares change
-
-3,075,925
-
Total reported value, excl. options
-
$87,370,000
-
Value change
-
-$80,695,326
-
Number of buys
-
20
-
Number of sells
-
-13
-
Price
-
$5.15
Significant Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q4 2021
37 filings reported holding CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 as of Q4 2021.
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,966,777 shares
of 55,833,616 outstanding shares and own 30.39% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6,991,003 shares), FMR LLC (3,417,564 shares), BlackRock Inc. (2,143,760 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,250,000 shares), Deep Track Capital, LP (647,057 shares), RTW INVESTMENTS, LP (450,000 shares), JANUS HENDERSON GROUP PLC (425,852 shares), BANK OF AMERICA CORP /DE/ (287,129 shares), Octagon Capital Advisors LP (279,921 shares), and Ikarian Capital, LLC (262,237 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.